Injectable Non-Thrombin Foam Increases Survival Rates for Severe Internal Bleeding in Recent Research Study

Medcura’s LifeFoam™ product demonstrates significant life-saving potential in massive noncompressible intra-abdominal hemorrhaging scenarios RIVERDALE, Md., Sept. 1, 2022 /PRNewswire/ — The injectable non-thrombin foam, LifeFoam™, created by Medcura Inc., a commercial-stage life science…

Click here to view original post